Mr Hyde NitroX Blue Razz Popsicle
Mr Hyde NitroX Blue Razz Popsicle is an "Other Combinations" supplement, earning an N+ Score of 64 and a "D" grade, placing it in the average tier. This product contains 5 ingredients, with 100% label transparency, providing clear dosage information for its components. Niacin, dosed at 25.000mg, is present at a clinically studied level, which research suggests may contribute to energy metabolism. Conversely, Calcium, at 28.000mg, is considered underdosed for its typical functional role. The formula incorporates a Strength Matrix (4.500g), Caffeine Matrix (420mg), and Intensity Matrix (653mg), though the specific constituents of these blends are not detailed in the available data. This product may be suitable for users looking for a transparently labeled combination supplement with a notable Niacin dose.
About This Product
Mr Hyde NitroX Blue Razz Popsicle by ProSupps is a joint & bone supplement containing 5 active ingredients. It has earned an N+ Score of 64/100 (Grade D).
Notable clinical-dose ingredients include Niacin.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Niacin | 25.000 mg | Optimal |
| Calcium | 28.000 mg | Under |
| Strength Matrix | 4.500 Gram(s) | N/A |
| Intensity Matrix | 653.000 mg | N/A |
| Caffeine Matrix | 420.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.